| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $825K | — |
| SG&A Expense | $600K | — |
| Operating Income | -$1.4M | — |
| Net Income | -$1.4M | — |
| EPS (Basic) | -$0.14 | — |
| EPS (Diluted) | -$0.14 | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $680K | -67.3% |
| Current Assets | $883K | -57.5% |
| Total Assets | $941K | -54.7% |
| Current Liabilities | $256K | +2826.9% |
| Total Liabilities | $256K | +2826.9% |
| Stockholders' Equity | $686K | -66.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.3M | — |
| Investing Cash Flow | -$63K | — |
| Financing Cash Flow | -$75K | — |